{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:04:56Z","timestamp":1787785496614,"version":"build-2784847793"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype of non-Hodgkin\u2019s lymphomas (NHL). DLBCL is an aggressive malignancy that displays a great heterogeneity in terms of morphology, genetics and biological behavior. While a sustained complete remission is obtained in the majority of patients with standard immunochemotherapy, patients with refractory of relapsed disease after first-line treatment have a poor prognosis. This patient group represents an important unmet need in lymphoma treatment. In recent years, improved understanding of the underlying molecular pathogenesis had led to new classification and prognostication tools, including the development of cell-free biomarkers in liquid biopsies. Although the majority of studies have focused on the use of cell-free fragments of DNA (cfDNA), there has been an increased interest in circulating-free coding and non-coding RNA, including messenger RNA (mRNA), microRNA (miRNA), long non-coding RNA (lncRNA) and circular RNA (circRNA), as well as RNA encapsulated in extracellular vesicles or tumor-educated platelets (TEPs).\u00a0We performed a systematic search in PubMed to identify articles that evaluated circulating RNA as diagnostic, subtype, treatment response or prognostic biomarkers in a human DLBCL population. A total of 35 articles met the inclusion criteria.\u00a0The aim of this systematic review is to present the current understanding of circulating RNA molecules as biomarker in DLBCL and to discuss their future potential.<\/jats:p>","DOI":"10.1186\/s40164-021-00208-3","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:17:14Z","timestamp":1613564234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7118-8344","authenticated-orcid":false,"given":"Philippe","family":"Decruyenaere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Vandesompele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"4","key":"208_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235\u201342.","journal-title":"N Engl J Med"},{"issue":"16","key":"208_CR2","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800\u20138.","journal-title":"Blood"},{"issue":"1","key":"208_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjh.14813","volume":"179","author":"U Farooq","year":"2017","unstructured":"Farooq U, Maurer MJ, Thompson CA, Thanarajasingam G, Inwards DJ, Micallef I, et al. Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy. Br J Haematol. 2017;179(1):50\u201360.","journal-title":"Br J Haematol"},{"issue":"14","key":"208_CR4","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1182\/blood-2016-05-719641","volume":"129","author":"D Rossi","year":"2017","unstructured":"Rossi D, Diop F, Spaccarotella E, Monti S, Zanni M, Rasi S, et al. Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 2017;129(14):1947\u201357.","journal-title":"Blood"},{"issue":"364","key":"208_CR5","doi-asserted-by":"publisher","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","volume":"8","author":"F Scherer","year":"2016","unstructured":"Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci Transl Med. 2016;8(364):364ra155.","journal-title":"Sci Transl Med"},{"issue":"28","key":"208_CR6","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","volume":"36","author":"DM Kurtz","year":"2018","unstructured":"Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, et al. Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma. J Clin Oncol. 2018;36(28):2845\u201353.","journal-title":"J Clin Oncol"},{"issue":"1","key":"208_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275\u201382.","journal-title":"Blood"},{"issue":"6769","key":"208_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503\u201311.","journal-title":"Nature"},{"issue":"15","key":"208_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378(15):1396\u2013407.","journal-title":"N Engl J Med"},{"issue":"5","key":"208_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679\u201390.","journal-title":"Nat Med"},{"key":"208_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1182\/blood-2019-132069","volume":"134","author":"MS Esfahani","year":"2019","unstructured":"Esfahani MS, Alig S, Kurtz DM, Soo J, Jin MC, Macaulay C. Towards non-invasive classification of DLBCL genetic subtypes by Ctdna profiling. Blood. 2019;134:551.","journal-title":"Blood"},{"issue":"11","key":"208_CR12","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/s41375-019-0509-6","volume":"33","author":"A Alkodsi","year":"2019","unstructured":"Alkodsi A, Cervera A, Zhang K, Louhimo R, Meriranta L, Pasanen A, et al. Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes. Leukemia. 2019;33(11):2662\u201372.","journal-title":"Leukemia"},{"issue":"18","key":"208_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJMoa032520","volume":"350","author":"IS Lossos","year":"2004","unstructured":"Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350(18):1828\u201337.","journal-title":"N Engl J Med"},{"issue":"1","key":"208_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm0102-68","volume":"8","author":"MA Shipp","year":"2002","unstructured":"Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8(1):68\u201374.","journal-title":"Nat Med"},{"issue":"25","key":"208_CR15","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937\u201347.","journal-title":"N Engl J Med"},{"issue":"14","key":"208_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors P","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors P. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329(14):987\u201394.","journal-title":"N Engl J Med"},{"issue":"8","key":"208_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nm.3884","volume":"21","author":"WH Wilson","year":"2015","unstructured":"Wilson WH, Young RM, Schmitz R, Yang Y, Pittaluga S, Wright G, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015;21(8):922\u20136.","journal-title":"Nat Med"},{"key":"208_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41375-020-0766-4","volume":"35","author":"KT Hartert","year":"2020","unstructured":"Hartert KT, Wenzl K, Krull JE, Manske M, Sarangi V, Asmann Y, et al. Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. Leukemia. 2020;35:522\u201333.","journal-title":"Leukemia"},{"key":"208_CR19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006578","author":"F Morschhauser","year":"2020","unstructured":"Morschhauser F, Feugier P, Flinn IW, Gasiorowski R, Greil R, Illes A, et al. A phase II study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma. Blood. 2020. https:\/\/doi.org\/10.1182\/blood.2020006578.","journal-title":"Blood"},{"issue":"5","key":"208_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1365-2141.2012.09209.x","volume":"158","author":"D Muringampurath-John","year":"2012","unstructured":"Muringampurath-John D, Jaye DL, Flowers CR, Saxe D, Chen Z, Lechowicz MJ, et al. Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. Br J Haematol. 2012;158(5):608\u201314.","journal-title":"Br J Haematol"},{"issue":"5740","key":"208_CR21","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1112014","volume":"309","author":"P Carninci","year":"2005","unstructured":"Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science. 2005;309(5740):1559\u201363.","journal-title":"Science"},{"issue":"12","key":"208_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"208_CR23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","volume":"48","author":"NB Tsui","year":"2002","unstructured":"Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48(10):1647\u201353.","journal-title":"Clin Chem"},{"key":"208_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-9966-31-38","volume":"31","author":"R Ma","year":"2012","unstructured":"Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res. 2012;31:38.","journal-title":"J Exp Clin Cancer Res"},{"key":"208_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.semcancer.2019.01.003","volume":"58","author":"C Sole","year":"2019","unstructured":"Sole C, Arnaiz E, Manterola L, Otaegui D, Lawrie CH. The circulating transcriptome as a source of cancer liquid biopsy biomarkers. Semin Cancer Biol. 2019;58:100\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"208_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654\u20139.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"208_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","volume":"122","author":"MM Denis","year":"2005","unstructured":"Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005;122(3):379\u201391.","journal-title":"Cell"},{"issue":"5","key":"208_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","volume":"28","author":"MG Best","year":"2015","unstructured":"Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, et al. RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell. 2015;28(5):666\u201376.","journal-title":"Cancer Cell"},{"issue":"4","key":"208_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1182\/blood-2014-04-512756","volume":"124","author":"S Schubert","year":"2014","unstructured":"Schubert S, Weyrich AS, Rowley JW. A tour through the transcriptional landscape of platelets. Blood. 2014;124(4):493\u2013502.","journal-title":"Blood"},{"issue":"12","key":"208_CR30","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","volume":"2","author":"HS Kuznetsov","year":"2012","unstructured":"Kuznetsov HS, Marsh T, Markens BA, Castano Z, Greene-Colozzi A, Hay SA, et al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov. 2012;2(12):1150\u201365.","journal-title":"Cancer Discov"},{"issue":"8","key":"208_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16(8):717\u201327.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"208_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"8777","key":"208_CR33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0140-6736(91)92100-G","volume":"338","author":"B Smith","year":"1991","unstructured":"Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet. 1991;338(8777):1227\u20139.","journal-title":"Lancet"},{"issue":"8","key":"208_CR34","first-page":"1961","volume":"5","author":"MS Kopreski","year":"1999","unstructured":"Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999;5(8):1961\u20135.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"208_CR35","doi-asserted-by":"publisher","first-page":"e0184094","DOI":"10.1371\/journal.pone.0184094","volume":"12","author":"MF Souza","year":"2017","unstructured":"Souza MF, Kuasne H, Barros-Filho MC, Ciliao HL, Marchi FA, Fuganti PE, et al. Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer. PLoS ONE. 2017;12(9):e0184094.","journal-title":"PLoS ONE"},{"issue":"4","key":"208_CR36","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1186\/bcr1760","volume":"9","author":"J Silva","year":"2007","unstructured":"Silva J, Garcia V, Garcia JM, Pena C, Dominguez G, Diaz R, et al. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast cancer research: BCR. 2007;9(4):R55.","journal-title":"Breast cancer research: BCR"},{"issue":"9","key":"208_CR37","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1245\/s10434-012-2272-z","volume":"19","author":"S Pucciarelli","year":"2012","unstructured":"Pucciarelli S, Rampazzo E, Briarava M, Maretto I, Agostini M, Digito M, et al. Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2012;19(9):3089\u201396.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"208_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/CBM-182231","volume":"25","author":"M Serilmez","year":"2019","unstructured":"Serilmez M, Ozgur E, Karaman S, Gezer U, Duranyildiz D. Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy. Cancer Biomark A. 2019;25(2):177\u201384.","journal-title":"Cancer Biomark A"},{"issue":"1","key":"208_CR39","doi-asserted-by":"publisher","first-page":"12943","DOI":"10.1038\/s41598-019-49445-x","volume":"9","author":"VW Xue","year":"2019","unstructured":"Xue VW, Cheung MT, Chan PT, Luk LLY, Lee VH, Au TC, et al. Non-invasive potential circulating mRNA Markers for colorectal adenoma using targeted sequencing. Sci Rep. 2019;9(1):12943.","journal-title":"Sci Rep"},{"issue":"1","key":"208_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-018-0735-1","volume":"37","author":"Y Tong","year":"2018","unstructured":"Tong Y, Zhao Z, Liu B, Bao A, Zheng H, Gu J, et al. 5\u2019\/ 3\u2019 imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer. J Exper Clin Cancer Res. 2018;37(1):68.","journal-title":"J Exper Clin Cancer Res"},{"issue":"12","key":"208_CR41","doi-asserted-by":"publisher","first-page":"e8173","DOI":"10.1371\/journal.pone.0008173","volume":"4","author":"V Garcia","year":"2009","unstructured":"Garcia V, Garcia JM, Silva J, Martin P, Pena C, Dominguez G, et al. Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications. PLoS ONE. 2009;4(12):e8173.","journal-title":"PLoS ONE"},{"issue":"21","key":"208_CR42","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","volume":"131","author":"L Pasqualucci","year":"2018","unstructured":"Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma. Blood. 2018;131(21):2307\u201319.","journal-title":"Blood"},{"issue":"6","key":"208_CR43","doi-asserted-by":"publisher","first-page":"150062","DOI":"10.1098\/rsob.150062","volume":"5","author":"J Chambers","year":"2015","unstructured":"Chambers J, Rabbitts TH. LMO2 at 25 years: a paradigm of chromosomal translocation proteins. Open Biol. 2015;5(6):150062.","journal-title":"Open Biol"},{"issue":"8","key":"208_CR44","doi-asserted-by":"publisher","first-page":"BSR20191162","DOI":"10.1042\/BSR20191162","volume":"39","author":"H Zhao","year":"2019","unstructured":"Zhao H, Kan Y, Wang X, Chen L, Ge P, Qian Z. Genetic polymorphism and transcriptional regulation of CREBBP gene in patient with diffuse large B-cell lymphoma. Biosci Rep. 2019;39(8):BSR20191162.","journal-title":"Biosci Rep"},{"issue":"1","key":"208_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/CBM-2012-0262","volume":"11","author":"FM Attia","year":"2011","unstructured":"Attia FM, Hassan AM, El-Maraghy NN, Ibrahium GH. Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy. Cancer Biomark A. 2011;11(1):41\u20137.","journal-title":"Cancer Biomark A"},{"issue":"5","key":"208_CR46","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/ATVBAHA.110.207464","volume":"31","author":"T Tamiya","year":"2011","unstructured":"Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A. Suppressors of cytokine signaling (SOCS) proteins and JAK\/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol. 2011;31(5):980\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"208_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s12253-013-9729-7","volume":"20","author":"Z Ujj","year":"2014","unstructured":"Ujj Z, Buglyo G, Udvardy M, Vargha G, Biro S, Rejto L. WT1 overexpression affecting clinical outcome in non-hodgkin lymphomas and adult acute lymphoblastic leukemia. Pathol Oncol Res. 2014;20(3):565\u201370.","journal-title":"Pathol Oncol Res"},{"key":"208_CR48","doi-asserted-by":"publisher","first-page":"19413","DOI":"10.1038\/srep19413","volume":"6","author":"T Yuan","year":"2016","unstructured":"Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, et al. Plasma extracellular RNA profiles in healthy and cancer patients. Sci Rep. 2016;6:19413.","journal-title":"Sci Rep"},{"issue":"6","key":"208_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6(6):590\u2013610.","journal-title":"Mol Oncol"},{"issue":"2","key":"208_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"10","key":"208_CR51","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997\u20131006.","journal-title":"Cell Res"},{"issue":"10","key":"208_CR52","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","volume":"101","author":"N Kosaka","year":"2010","unstructured":"Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101(10):2087\u201392.","journal-title":"Cancer Sci"},{"issue":"5","key":"208_CR53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","volume":"141","author":"CH Lawrie","year":"2008","unstructured":"Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141(5):672\u20135.","journal-title":"Br J Haematol"},{"issue":"32","key":"208_CR54","doi-asserted-by":"publisher","first-page":"22850","DOI":"10.18632\/oncotarget.25230","volume":"9","author":"M Lopez-Santillan","year":"2018","unstructured":"Lopez-Santillan M, Larrabeiti-Etxebarria A, Arzuaga-Mendez J, Lopez-Lopez E, Garcia-Orad A. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review. Oncotarget. 2018;9(32):22850\u201361.","journal-title":"Oncotarget"},{"issue":"4","key":"208_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00277-011-1350-9","volume":"91","author":"C Fang","year":"2012","unstructured":"Fang C, Zhu DX, Dong HJ, Zhou ZJ, Wang YH, Liu L, et al. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol. 2012;91(4):553\u20139.","journal-title":"Ann Hematol"},{"issue":"4","key":"208_CR56","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.18632\/oncotarget.6624","volume":"7","author":"NM Borges","year":"2016","unstructured":"Borges NM, do Vale Elias M, Fook-Alves VL, Andrade TA, de Conti ML, Macedo MP, et al. Angiomirs expression profiling in diffuse large B-cell lymphoma. Oncotarget. 2016;7(4):4806\u201316.","journal-title":"Oncotarget"},{"issue":"11","key":"208_CR57","first-page":"15019","volume":"8","author":"J Li","year":"2015","unstructured":"Li J, Fu R, Yang L, Tu W. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma. Int J Clin Exp Pathol. 2015;8(11):15019\u201324.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"208_CR58","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3892\/ol.2015.3866","volume":"11","author":"WX Yuan","year":"2016","unstructured":"Yuan WX, Gui YX, Na WN, Chao J, Yang X. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients. Oncol Lett. 2016;11(1):423\u201332.","journal-title":"Oncol Lett"},{"issue":"5","key":"208_CR59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/ejh.12263","volume":"92","author":"W Chen","year":"2014","unstructured":"Chen W, Wang H, Chen H, Liu S, Lu H, Kong D, et al. Clinical significance and detection of microRNA-21\u00a0in serum of patients with diffuse large B-cell lymphoma in Chinese population. Eur J Haematol. 2014;92(5):407\u201312.","journal-title":"Eur J Haematol"},{"issue":"1","key":"208_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","volume":"18","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, et al. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8 + T cells. Mol Cancer. 2019;18(1):54.","journal-title":"Mol Cancer"},{"issue":"1","key":"208_CR61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13046-017-0551-z","volume":"36","author":"Z Zheng","year":"2017","unstructured":"Zheng Z, Xu PP, Wang L, Zhao HJ, Weng XQ, Zhong HJ, et al. MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS\/ICOSL-mediated interaction of Treg cells with endothelial cells. J Exper Clin Cancer Res. 2017;36(1):82.","journal-title":"J Exper Clin Cancer Res"},{"key":"208_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.gene.2017.11.022","volume":"642","author":"Y Meng","year":"2018","unstructured":"Meng Y, Quan L, Liu A. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions. Gene. 2018;642:205\u201311.","journal-title":"Gene"},{"issue":"11","key":"208_CR63","doi-asserted-by":"publisher","first-page":"e0187722","DOI":"10.1371\/journal.pone.0187722","volume":"12","author":"D Khare","year":"2017","unstructured":"Khare D, Goldschmidt N, Bardugo A, Gur-Wahnon D, Ben-Dov IZ, Avni B. Plasma microRNA profiling: exploring better biomarkers for lymphoma surveillance. PLoS ONE. 2017;12(11):e0187722.","journal-title":"PLoS ONE"},{"key":"208_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4236\/ojbd.2015.54008","volume":"5","author":"K Inada","year":"2015","unstructured":"Inada K, Okoshi Y, Cho Y, Saito H, Iijima T, Hori M, et al. Availability of circulating MicroRNAs as a biomarker for early diagnosis of diffuse large B-cell lymphoma. Open J Blood Dis. 2015;5:48\u201358.","journal-title":"Open J Blood Dis"},{"issue":"78","key":"208_CR65","doi-asserted-by":"publisher","first-page":"34644","DOI":"10.18632\/oncotarget.26141","volume":"9","author":"Q Cui","year":"2018","unstructured":"Cui Q, Vari F, Cristino AS, Salomon C, Rice GE, Sabdia MB, et al. Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma. Oncotarget. 2018;9(78):34644\u201357.","journal-title":"Oncotarget"},{"issue":"1","key":"208_CR66","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1038\/s41598-020-66062-1","volume":"10","author":"S Jorgensen","year":"2020","unstructured":"Jorgensen S, Paulsen IW, Hansen JW, Tholstrup D, Hother C, Sorensen E, et al. The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples. Sci Rep. 2020;10(1):9637.","journal-title":"Sci Rep"},{"issue":"5","key":"208_CR67","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ijc.28563","volume":"135","author":"JW Yan","year":"2014","unstructured":"Yan JW, Lin JS, He XX. The emerging role of miR-375&nbsp;in cancer. Int J Cancer. 2014;135(5):1011\u20138.","journal-title":"Int J Cancer"},{"issue":"D1","key":"208_CR68","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296-302.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"208_CR69","doi-asserted-by":"publisher","first-page":"17161","DOI":"10.1038\/s41598-019-52985-x","volume":"9","author":"A Beheshti","year":"2019","unstructured":"Beheshti A, Stevenson K, Vanderburg C, Ravi D, McDonald JT, Christie AL, et al. Identification of circulating serum multi-microRNA signatures in human DLBCL models. Sci Rep. 2019;9(1):17161.","journal-title":"Sci Rep"},{"issue":"1","key":"208_CR70","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11033-018-4554-4","volume":"46","author":"SB Tuncer","year":"2019","unstructured":"Tuncer SB, Akdeniz D, Celik B, Kilic S, Sukruoglu O, Avsar M, et al. The expression levels of miRNA-15a and miRNA-16-1&nbsp;in circulating tumor cells of patients with diffuse large B-cell lymphoma. Mol Biol Rep. 2019;46(1):975\u201380.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"208_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.2010.1919","volume":"305","author":"M Fabbri","year":"2011","unstructured":"Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, et al. Association of a microRNA\/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011;305(1):59\u201367.","journal-title":"JAMA"},{"issue":"2","key":"208_CR72","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2009.69","volume":"17","author":"RI Aqeilan","year":"2010","unstructured":"Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1&nbsp;in cancer: discovery, function and future perspectives. Cell Death Differ. 2010;17(2):215\u201320.","journal-title":"Cell Death Differ"},{"issue":"9","key":"208_CR73","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/QAD.0b013e3283543e0e","volume":"26","author":"DR Thapa","year":"2012","unstructured":"Thapa DR, Bhatia K, Bream JH, D\u2019Souza G, Rinaldo CR, Wolinsky S, et al. B-cell activation induced microRNA-21\u00a0is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas. AIDS. 2012;26(9):1177\u201380.","journal-title":"AIDS"},{"issue":"1","key":"208_CR74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4049\/jimmunol.1101563","volume":"189","author":"NA Barnes","year":"2012","unstructured":"Barnes NA, Stephenson S, Cocco M, Tooze RM, Doody GM. BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation. J Immunol (Baltimore, Md: 1950). 2012;189(1):253\u201360.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"7311","key":"208_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"PP Medina","year":"2010","unstructured":"Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 2010;467(7311):86\u201390.","journal-title":"Nature"},{"issue":"4","key":"208_CR76","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","volume":"39","author":"D Iliopoulos","year":"2010","unstructured":"Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 2010;39(4):493\u2013506.","journal-title":"Mol Cell"},{"issue":"2","key":"208_CR77","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/cancers11020144","volume":"11","author":"A Larrabeiti-Etxebarria","year":"2019","unstructured":"Larrabeiti-Etxebarria A, Lopez-Santillan M, Santos-Zorrozua B, Lopez-Lopez E, Garcia-Orad A. Systematic review of the potential of microRNAs in diffuse large B cell lymphoma. Cancers. 2019;11(2):144.","journal-title":"Cancers"},{"key":"208_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.leukres.2018.05.006","volume":"70","author":"M Ahmadvand","year":"2018","unstructured":"Ahmadvand M, Eskandari M, Pashaiefar H, Yaghmaie M, Manoochehrabadi S, Khakpour G, et al. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma. Leukemia Res. 2018;70:45\u20138.","journal-title":"Leukemia Res"},{"issue":"3","key":"208_CR79","first-page":"207","volume":"34","author":"AML Bedewy","year":"2017","unstructured":"Bedewy AML, Elmaghraby SM, Shehata AA, Kandil NS. Prognostic value of miRNA-155 expression in B-cell non-hodgkin lymphoma. Turk J Haematol. 2017;34(3):207\u201312.","journal-title":"Turk J Haematol"},{"key":"208_CR80","doi-asserted-by":"publisher","first-page":"1179299X1878109","DOI":"10.1177\/1179299X18781095","volume":"10","author":"C Bouvy","year":"2018","unstructured":"Bouvy C, Wannez A, George F, Graux C, Chatelain C, Dogne JM. Circulating microRNAs as biomarkers in diffuse large b-cell lymphoma: a pilot prospective longitudinal clinical study. Biomark Cancer. 2018;10:1179299X18781095.","journal-title":"Biomark Cancer"},{"issue":"10","key":"208_CR81","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00277-014-2111-3","volume":"93","author":"G Song","year":"2014","unstructured":"Song G, Gu L, Li J, Tang Z, Liu H, Chen B, et al. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. Ann Hematol. 2014;93(10):1735\u201343.","journal-title":"Ann Hematol"},{"issue":"4","key":"208_CR82","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ncrna.2020.10.001","volume":"5","author":"OR Fajardo-Ramirez","year":"2020","unstructured":"Fajardo-Ramirez OR, Villela L, Campa-Carranza JN, Perez-Maya AA, Borrego-Soto G, Wah-Suarez MI, et al. miRNA signature associated with R-CHOP refractoriness in patients diagnosed with diffuse large B cell lymphoma. Non-coding RNA Res. 2020;5(4):185\u201390.","journal-title":"Non-coding RNA Res"},{"key":"208_CR83","doi-asserted-by":"publisher","first-page":"102818","DOI":"10.1016\/j.critrevonc.2019.102818","volume":"144","author":"CY Ting","year":"2019","unstructured":"Ting CY, Liew SM, Price A, Gan GG, Bee-Lan Ong D, Tan SY, et al. Clinical significance of aberrant microRNAs expression in predicting disease relapse\/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis. Crit Rev Oncol Hematol. 2019;144:102818.","journal-title":"Crit Rev Oncol Hematol"},{"key":"208_CR84","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/1878-0261.12834","volume":"15","author":"R Sun","year":"2020","unstructured":"Sun R, Zheng Z, Wang L, Cheng S, Shi Q, Qu B, et al. A novel prognostic model based on 4 circulating miRNAs in diffuse large B-cell lymphoma: implications for the roles of MDSCs and Th17 cells in lymphoma progression. Mol Oncol. 2020;15:246\u201361.","journal-title":"Mol Oncol"},{"issue":"3","key":"208_CR85","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","volume":"13","author":"P Wolf","year":"1967","unstructured":"Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13(3):269\u201388.","journal-title":"Br J Haematol"},{"issue":"1","key":"208_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/BCJ20160006","volume":"474","author":"SK Gopal","year":"2017","unstructured":"Gopal SK, Greening DW, Rai A, Chen M, Xu R, Shafiq A, et al. Extracellular vesicles: their role in cancer biology and epithelial-mesenchymal transition. Biochem J. 2017;474(1):21\u201345.","journal-title":"Biochem J"},{"key":"208_CR87","doi-asserted-by":"publisher","first-page":"9702562","DOI":"10.1155\/2019\/9702562","volume":"2019","author":"MB Khawar","year":"2019","unstructured":"Khawar MB, Abbasi MH, Siddique Z, Arif A, Sheikh N. An update on novel therapeutic warfronts of extracellular vesicles (EVs) in cancer treatment: where we are standing right now and where to go in the future. Oxidative Med Cell Longev. 2019;2019:9702562.","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"208_CR88","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"key":"208_CR89","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.cellbio.23.090506.123319","volume":"23","author":"RC Piper","year":"2007","unstructured":"Piper RC, Katzmann DJ. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol. 2007;23:519\u201347.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"208_CR90","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1600-0854.2008.00734.x","volume":"9","author":"JS Schorey","year":"2008","unstructured":"Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic. 2008;9(6):871\u201381.","journal-title":"Traffic"},{"issue":"12","key":"208_CR91","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1101\/gad.192351.112","volume":"26","author":"C D\u2019Souza-Schorey","year":"2012","unstructured":"D\u2019Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012;26(12):1287\u201399.","journal-title":"Genes Dev"},{"key":"208_CR92","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fonc.2018.00066","volume":"8","author":"C Rajagopal","year":"2018","unstructured":"Rajagopal C, Harikumar KB. The origin and functions of exosomes in cancer. Front Oncol. 2018;8:66.","journal-title":"Front Oncol"},{"key":"208_CR93","doi-asserted-by":"publisher","first-page":"42741","DOI":"10.1038\/srep42741","volume":"7","author":"V Domenyuk","year":"2017","unstructured":"Domenyuk V, Zhong Z, Stark A, Xiao N, O\u2019Neill HA, Wei X, et al. Plasma exosome profiling of cancer patients by a next generation systems biology approach. Sci Rep. 2017;7:42741.","journal-title":"Sci Rep"},{"issue":"6478","key":"208_CR94","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY). 2020;367(6478):eaau6977.","journal-title":"Science (New York, NY)"},{"issue":"4","key":"208_CR95","first-page":"1620","volume":"23","author":"XB Xiao","year":"2019","unstructured":"Xiao XB, Gu Y, Sun DL, Ding LY, Yuan XG, Jiang HW, et al. Effect of rituximab combined with chemotherapy on the expression of serum exosome miR-451a in patients with diffuse large b-cell lymphoma. Eur Rev Med Pharmacol Sci. 2019;23(4):1620\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"208_CR96","first-page":"1182","volume":"10","author":"C Di","year":"2018","unstructured":"Di C, Jiang Y, Li M, Juan X, Xu C. Circulating exosomal microRNA signature as a noninvasive biomarker for diagnosis of diffuse large B-cell lymphoma. Blood. 2018;10:1182.","journal-title":"Blood"},{"issue":"4","key":"208_CR97","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/onc.2017.332","volume":"37","author":"C Chang","year":"2018","unstructured":"Chang C, Liu J, He W, Qu M, Huang X, Deng Y, et al. A regulatory circuit HP1gamma\/miR-451a\/c-Myc promotes prostate cancer progression. Oncogene. 2018;37(4):415\u201326.","journal-title":"Oncogene"},{"issue":"10","key":"208_CR98","doi-asserted-by":"publisher","first-page":"13751","DOI":"10.1007\/s13277-016-5219-3","volume":"37","author":"H Guo","year":"2016","unstructured":"Guo H, Nan Y, Zhen Y, Zhang Y, Guo L, Yu K, et al. miRNA-451&nbsp;inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1. Tumour Biol. 2016;37(10):13751\u201361.","journal-title":"Tumour Biol"},{"issue":"7","key":"208_CR99","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1182\/blood-2017-12-821843","volume":"132","author":"SC Rutherford","year":"2018","unstructured":"Rutherford SC, Fachel AA, Li S, Sawh S, Muley A, Ishii J, et al. Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood. 2018;132(7):e13\u201323.","journal-title":"Blood"},{"key":"208_CR100","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1182\/blood-2017-08-800730","volume":"130","author":"S Rutherford","year":"2017","unstructured":"Rutherford S, Fachel A, Sheng L, Yanwen J, Dominguez MP, Betel D, et al. DLBCL-derived exosomes provide key insights into genomic landscape in cell of origin and may lead to a novel method of surveillance and therapeutic intervention. Blood. 2017;130:5132.","journal-title":"Blood"},{"issue":"8","key":"208_CR101","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1080\/10428194.2018.1563692","volume":"60","author":"N Zare","year":"2019","unstructured":"Zare N, Haghjooy Javanmard S, Mehrzad V, Eskandari N, Kefayat A. Evaluation of exosomal miR-155, let-7&nbsp;g and let-7&nbsp;i levels as a potential noninvasive biomarker among refractory\/relapsed patients, responsive patients and patients receiving R-CHOP. Leukemia Lymphoma. 2019;60(8):1877\u201389.","journal-title":"Leukemia Lymphoma"},{"issue":"1","key":"208_CR102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/epi-2018-0123","volume":"11","author":"Y Feng","year":"2019","unstructured":"Feng Y, Zhong M, Zeng S, Wang L, Liu P, Xiao X, et al. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance. Epigenomics. 2019;11(1):35\u201351.","journal-title":"Epigenomics"},{"issue":"31","key":"208_CR103","doi-asserted-by":"publisher","first-page":"50949","DOI":"10.18632\/oncotarget.16435","volume":"8","author":"M Provencio","year":"2017","unstructured":"Provencio M, Rodriguez M, Cantos B, Sabin P, Quero C, Garcia-Arroyo FR, et al. mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish Lymphoma Oncology Group. Oncotarget. 2017;8(31):50949\u201357.","journal-title":"Oncotarget"},{"issue":"2","key":"208_CR104","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1158\/1078-0432.CCR-15-0577","volume":"22","author":"R Koch","year":"2016","unstructured":"Koch R, Aung T, Vogel D, Chapuy B, Wenzel D, Becker S, et al. Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantrone. Clin Cancer Res. 2016;22(2):395\u2013404.","journal-title":"Clin Cancer Res"},{"issue":"37","key":"208_CR105","doi-asserted-by":"publisher","first-page":"15336","DOI":"10.1073\/pnas.1102855108","volume":"108","author":"T Aung","year":"2011","unstructured":"Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci USA. 2011;108(37):15336\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"208_CR106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/BLCTT.S130826","volume":"7","author":"HR Ferguson Bennit","year":"2017","unstructured":"Ferguson Bennit HR, Gonda A, Oppegard LJ, Chi DP, Khan S, Wall NR. Uptake of lymphoma-derived exosomes by peripheral blood leukocytes. Blood Lymphat Cancer Targets Ther. 2017;7:9\u201323.","journal-title":"Blood Lymphat Cancer Targets Ther"},{"issue":"5","key":"208_CR107","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00281-010-0233-9","volume":"33","author":"N Chaput","year":"2011","unstructured":"Chaput N, Thery C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol. 2011;33(5):419\u201340.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"208_CR108","first-page":"40","volume":"22","author":"N Zare","year":"2020","unstructured":"Zare N, Haghjooy Javanmard SH, Mehrzad V, Eskandari N, Andalib AR. Effect of plasma-derived exosomes of refractory\/relapsed or responsive patients with diffuse large B-cell lymphoma on natural killer cells functions. Cell J. 2020;22(1):40\u201354.","journal-title":"Cell J"},{"issue":"2","key":"208_CR109","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio M, Hu T, Pai CC, Chu B, Belair CD, Chang A, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell. 2019;177(2):414\u201327 e13.","journal-title":"Cell"},{"issue":"1","key":"208_CR110","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13046-018-0863-7","volume":"37","author":"Z Chen","year":"2018","unstructured":"Chen Z, You L, Wang L, Huang X, Liu H, Wei JY, et al. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo. J Exper Clin Cancer Res. 2018;37(1):190.","journal-title":"J Exper Clin Cancer Res"},{"issue":"14","key":"208_CR111","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1182\/blood-2013-08-523886","volume":"123","author":"R Koch","year":"2014","unstructured":"Koch R, Demant M, Aung T, Diering N, Cicholas A, Chapuy B, et al. Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma. Blood. 2014;123(14):2189\u201398.","journal-title":"Blood"},{"key":"208_CR112","doi-asserted-by":"publisher","first-page":"17319","DOI":"10.1038\/srep17319","volume":"5","author":"MA Livshits","year":"2015","unstructured":"Livshits MA, Khomyakova E, Evtushenko EG, Lazarev VN, Kulemin NA, Semina SE, et al. Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2015;5:17319.","journal-title":"Sci Rep"},{"key":"208_CR113","doi-asserted-by":"crossref","unstructured":"Van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014;3.","DOI":"10.3402\/jev.v3.24858"},{"issue":"12","key":"208_CR114","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/atm.2017.03.95","volume":"5","author":"I Furi","year":"2017","unstructured":"Furi I, Momen-Heravi F, Szabo G. Extracellular vesicle isolation: present and future. Ann Transl Med. 2017;5(12):263.","journal-title":"Ann Transl Med"},{"issue":"1","key":"208_CR115","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/annonc\/mdx542","volume":"29","author":"J Castillo","year":"2018","unstructured":"Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 2018;29(1):223\u20139.","journal-title":"Ann Oncol"},{"issue":"7235","key":"208_CR116","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature07672","volume":"458","author":"M Guttman","year":"2009","unstructured":"Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223\u20137.","journal-title":"Nature"},{"issue":"43","key":"208_CR117","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/onc.2011.621","volume":"31","author":"R Spizzo","year":"2012","unstructured":"Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31(43):4577\u201387.","journal-title":"Oncogene"},{"key":"208_CR118","first-page":"9085195","volume":"2016","author":"T Shi","year":"2016","unstructured":"Shi T, Gao G, Cao Y. Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. Dis Mark. 2016;2016:9085195.","journal-title":"Dis Mark"},{"issue":"3","key":"208_CR119","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155\u20139.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"208_CR120","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.ajpath.2016.05.011","volume":"186","author":"MM Tayari","year":"2016","unstructured":"Tayari MM, Winkle M, Kortman G, Sietzema J, de Jong D, Terpstra M, et al. Long noncoding RNA expression profiling in normal B-cell subsets and Hodgkin lymphoma reveals Hodgkin and Reed-Sternberg cell-specific long noncoding RNAs. Am J Pathol. 2016;186(9):2462\u201372.","journal-title":"Am J Pathol"},{"issue":"7","key":"208_CR121","doi-asserted-by":"publisher","first-page":"e10-9","DOI":"10.1182\/blood-2015-11-680843","volume":"128","author":"TF Brazao","year":"2016","unstructured":"Brazao TF, Johnson JS, Muller J, Heger A, Ponting CP, Tybulewicz VL. Long noncoding RNAs in B-cell development and activation. Blood. 2016;128(7):e10-9.","journal-title":"Blood"},{"issue":"9","key":"208_CR122","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3390\/ijms19092475","volume":"19","author":"M Dahl","year":"2018","unstructured":"Dahl M, Kristensen LS, Gronbaek K. Long non-coding RNAs guide the fine-tuning of gene regulation in B-cell development and malignancy. Int J Mol Sci. 2018;19(9):2475.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"208_CR123","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1182\/blood-2015-07-657999","volume":"126","author":"Z Lu","year":"2015","unstructured":"Lu Z, Pannunzio NR, Greisman HA, Casero D, Parekh C, Lieber MR. Convergent BCL6 and lncRNA promoters demarcate the major breakpoint region for BCL6 translocations. Blood. 2015;126(14):1730\u20131.","journal-title":"Blood"},{"key":"208_CR124","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13073-015-0230-7","volume":"7","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang Y, Du W, Fairchild L, Melnick A, Elemento O. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma. Genome Med. 2015;7:110.","journal-title":"Genome Med"},{"key":"208_CR125","doi-asserted-by":"publisher","first-page":"27842","DOI":"10.1038\/srep27842","volume":"6","author":"J Sun","year":"2016","unstructured":"Sun J, Cheng L, Shi H, Zhang Z, Zhao H, Wang Z, et al. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma. Sci Rep. 2016;6:27842.","journal-title":"Sci Rep"},{"issue":"1","key":"208_CR126","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-017-0580-4","volume":"16","author":"M Zhou","year":"2017","unstructured":"Zhou M, Zhao H, Xu W, Bao S, Cheng L, Sun J. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer. 2017;16(1):16.","journal-title":"Mol Cancer"},{"issue":"3","key":"208_CR127","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3892\/or.2017.5821","volume":"38","author":"HY Gao","year":"2017","unstructured":"Gao HY, Wu B, Yan W, Gong ZM, Sun Q, Wang HH, et al. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma. Oncol Rep. 2017;38(3):1363\u201372.","journal-title":"Oncol Rep"},{"issue":"9","key":"208_CR128","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.prp.2018.08.006","volume":"214","author":"F Dousti","year":"2018","unstructured":"Dousti F, Shahrisa A, Ansari H, Hajjari M, Tahmasebi Birgani Y, Mohammadiasl J, et al. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: an in silico analysis. Pathol Res Pract. 2018;214(9):1462\u20136.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"208_CR129","first-page":"1831","volume":"63","author":"P Xu","year":"2017","unstructured":"Xu P, Chen X, Su P. A pooled analysis of the clinical utilities of long non-coding RNA based molecular signature for diffuse large B cell lymphoma. Clin Lab. 2017;63(11):1831\u201340.","journal-title":"Clin Lab"},{"issue":"1","key":"208_CR130","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-016-0524-4","volume":"15","author":"P Qi","year":"2016","unstructured":"Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016;15(1):39.","journal-title":"Mol Cancer"},{"key":"208_CR131","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cca.2014.02.010","volume":"431","author":"M Isin","year":"2014","unstructured":"Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U, et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014;431:255\u20139.","journal-title":"Clin Chim Acta"},{"issue":"42","key":"208_CR132","doi-asserted-by":"publisher","first-page":"72182","DOI":"10.18632\/oncotarget.20053","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang M, Xu H, Wang Y, Li Z, Chang Y, et al. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK\/ERK signaling pathway. Oncotarget. 2017;8(42):72182\u201396.","journal-title":"Oncotarget"},{"issue":"1","key":"208_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-015-0396-8","volume":"17","author":"W Peng","year":"2017","unstructured":"Peng W, Wu J, Feng J. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy. Clin Exper Med. 2017;17(1):1\u20138.","journal-title":"Clin Exper Med"},{"issue":"21","key":"208_CR134","doi-asserted-by":"publisher","first-page":"34374","DOI":"10.18632\/oncotarget.16163","volume":"8","author":"S Zhao","year":"2017","unstructured":"Zhao S, Fang S, Liu Y, Li X, Liao S, Chen J, et al. The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma. Oncotarget. 2017;8(21):34374\u201386.","journal-title":"Oncotarget"},{"key":"208_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biopha.2015.12.001","volume":"77","author":"W Peng","year":"2016","unstructured":"Peng W, Feng J. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016;77:65\u201371.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"208_CR136","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbrc.2019.01.105","volume":"510","author":"X Shi","year":"2019","unstructured":"Shi X, Cui Z, Liu X, Wu S, Wu Y, Fang F, et al. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt\/beta-catenin signaling pathway. Biochem Biophys Res Commun. 2019;510(4):594\u2013600.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"208_CR137","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10238-015-0350-9","volume":"16","author":"W Peng","year":"2016","unstructured":"Peng W, Fan H, Wu G, Wu J, Feng J. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity. Clin Exper Med. 2016;16(2):177\u201382.","journal-title":"Clin Exper Med"},{"key":"208_CR138","doi-asserted-by":"publisher","first-page":"104451","DOI":"10.1016\/j.yexmp.2020.104451","volume":"115","author":"H Meng","year":"2020","unstructured":"Meng H, Zhao B, Wang Y. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt\/beta-catenin signaling pathway. Exp Mol Pathol. 2020;115:104451.","journal-title":"Exp Mol Pathol"},{"key":"208_CR139","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biopha.2016.02.032","volume":"79","author":"W Peng","year":"2016","unstructured":"Peng W, Wu J, Feng J. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016;79:188\u201393.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"208_CR140","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1097\/JTO.0b013e3182307eac","volume":"6","author":"LH Schmidt","year":"2011","unstructured":"Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D, et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J thorac Oncol. 2011;6(12):1984\u201392.","journal-title":"J thorac Oncol"},{"issue":"3","key":"208_CR141","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s12032-011-0004-z","volume":"29","author":"MC Lai","year":"2012","unstructured":"Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29(3):1810\u20136.","journal-title":"Med Oncol"},{"key":"208_CR142","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopha.2017.02.011","volume":"89","author":"LJ Li","year":"2017","unstructured":"Li LJ, Chai Y, Guo XJ, Chu SL, Zhang LS. The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother. 2017;89:939\u201348.","journal-title":"Biomed Pharmacother"},{"issue":"7291","key":"208_CR143","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"RA Gupta","year":"2010","unstructured":"Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071\u20136.","journal-title":"Nature"},{"issue":"5","key":"208_CR144","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4132\/jptm.2016.06.06","volume":"50","author":"EJ Oh","year":"2016","unstructured":"Oh EJ, Kim SH, Yang WI, Ko YH, Yoon SO. Long non-coding RNA HOTAIR expression in diffuse large B-cell lymphoma: in relation to polycomb repressive complex pathway proteins and H3K27 trimethylation. J Pathol Transl Med. 2016;50(5):369\u201376.","journal-title":"J Pathol Transl Med"},{"issue":"6","key":"208_CR145","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.3892\/mmr.2016.5190","volume":"13","author":"Y Yan","year":"2016","unstructured":"Yan Y, Han J, Li Z, Yang H, Sui Y, Wang M. Elevated RNA expression of long noncoding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma. Mol Med Rep. 2016;13(6):5125\u201331.","journal-title":"Mol Med Rep"},{"key":"208_CR146","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12935-020-1158-6","volume":"20","author":"CS Qian","year":"2020","unstructured":"Qian CS, Li LJ, Huang HW, Yang HF, Wu DP. MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma. Cancer Cell Int. 2020;20:87.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"208_CR147","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/CBM-160221","volume":"23","author":"L Deng","year":"2018","unstructured":"Deng L, Jiang L, Tseng KF, Liu Y, Zhang X, Dong R, et al. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma. Cancer Biomark A. 2018;23(2):157\u201364.","journal-title":"Cancer Biomark A"},{"issue":"11","key":"208_CR148","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1111\/jcmm.14601","volume":"23","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Li Y, Guo Y, Hu L, Xiao Z, Liu X, et al. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p\/PIM1 axis. J Cell Mol Med. 2019;23(11):7395\u2013405.","journal-title":"J Cell Mol Med"},{"issue":"1\u20132","key":"208_CR149","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-019-03588-7","volume":"461","author":"H Cheng","year":"2019","unstructured":"Cheng H, Yan Z, Wang X, Cao J, Chen W, Qi K, et al. Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma. Mol Cell Biochem. 2019;461(1\u20132):47\u201356.","journal-title":"Mol Cell Biochem"},{"key":"208_CR150","doi-asserted-by":"publisher","first-page":"116335","DOI":"10.1016\/j.lfs.2019.03.040","volume":"231","author":"QM Wang","year":"2019","unstructured":"Wang QM, Lian GY, Song Y, Huang YF, Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335.","journal-title":"Life Sci"},{"issue":"4","key":"208_CR151","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41419-019-1479-3","volume":"10","author":"CC Zhao","year":"2019","unstructured":"Zhao CC, Jiao Y, Zhang YY, Ning J, Zhang YR, Xu J, et al. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt\/beta-catenin pathway by sponging miR-135b-5p to elevate expression of APC. Cell Death Dis. 2019;10(4):252.","journal-title":"Cell Death Dis"},{"issue":"10","key":"208_CR152","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41419-019-1886-5","volume":"10","author":"L Zhao","year":"2019","unstructured":"Zhao L, Liu Y, Zhang J, Liu Y, Qi Q. LncRNA SNHG14\/miR-5590-3p\/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1\/PD-L1 checkpoint. Cell Death Dis. 2019;10(10):731.","journal-title":"Cell Death Dis"},{"key":"208_CR153","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.2147\/OTT.S249429","volume":"13","author":"LY Chen","year":"2020","unstructured":"Chen LY, Zhang XM, Han BQ, Dai HB. Long noncoding RNA SNHG12 indicates the prognosis and accelerates tumorigenesis of diffuse large B-cell lymphoma through sponging microR-195. OncoTargets Ther. 2020;13:5563\u201374.","journal-title":"OncoTargets Ther"},{"key":"208_CR154","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.2147\/OTT.S253330","volume":"13","author":"X Huang","year":"2020","unstructured":"Huang X, Qian W, Ye X. Long noncoding RNAs in diffuse large B-cell lymphoma: current advances and perspectives. OncoTargets Ther. 2020;13:4295\u2013303.","journal-title":"OncoTargets Ther"},{"issue":"6","key":"208_CR155","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125\u201334.","journal-title":"Cell"},{"issue":"7441","key":"208_CR156","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333\u20138.","journal-title":"Nature"},{"issue":"1","key":"208_CR157","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","volume":"66","author":"NR Pamudurti","year":"2017","unstructured":"Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, et al. Translation of CircRNAs. Mol Cell. 2017;66(1):9\u201321 e7.","journal-title":"Mol Cell"},{"issue":"2","key":"208_CR158","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141\u201357.","journal-title":"RNA"},{"issue":"7441","key":"208_CR159","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature11956","volume":"495","author":"KS Kosik","year":"2013","unstructured":"Kosik KS. Molecular biology: circles reshape the RNA world. Nature. 2013;495(7441):322\u20134.","journal-title":"Nature"},{"issue":"16","key":"208_CR160","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.1093\/nar\/gky721","volume":"46","author":"BP Nicolet","year":"2018","unstructured":"Nicolet BP, Engels S, Aglialoro F, van den Akker E, von Lindern M, Wolkers MC. Circular RNA expression in human hematopoietic cells is widespread and cell-type specific. Nucleic Acids Res. 2018;46(16):8168\u201380.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"208_CR161","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555\u201365.","journal-title":"Oncogene"},{"issue":"12","key":"208_CR162","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41374-018-0108-6","volume":"98","author":"M Dahl","year":"2018","unstructured":"Dahl M, Daugaard I, Andersen MS, Hansen TB, Gronbaek K, Kjems J, et al. Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies. Lab Invest. 2018;98(12):1657\u201369.","journal-title":"Lab Invest"},{"key":"208_CR163","doi-asserted-by":"publisher","first-page":"9351","DOI":"10.2147\/CMAR.S263222","volume":"12","author":"X Chen","year":"2020","unstructured":"Chen X, Xie X, Zhou W. CircCFL1\/MiR-107 axis targeting HMGB1 promotes the malignant progression of diffuse large B-cell lymphoma tumors. Cancer Manag Res. 2020;12:9351\u201362.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"208_CR164","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/leu.2017.94","volume":"31","author":"A Dzikiewicz-Krawczyk","year":"2017","unstructured":"Dzikiewicz-Krawczyk A, Kok K, Slezak-Prochazka I, Robertus JL, Bruining J, Tayari MM, et al. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma. Leukemia. 2017;31(6):1470\u20133.","journal-title":"Leukemia"},{"issue":"9","key":"208_CR165","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/cdd.2017.86","volume":"24","author":"Q Yang","year":"2017","unstructured":"Yang Q, Du WW, Wu N, Yang W, Awan FM, Fang L, et al. A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation. Cell Death Differ. 2017;24(9):1609\u201320.","journal-title":"Cell Death Differ"},{"issue":"2","key":"208_CR166","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2016.03.020","volume":"165","author":"J Guarnerio","year":"2016","unstructured":"Guarnerio J, Bezzi M, Jeong JC, Paffenholz SV, Berry K, Naldini MM, et al. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations. Cell. 2016;165(2):289\u2013302.","journal-title":"Cell"},{"issue":"19","key":"208_CR167","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.18632\/aging.102122","volume":"11","author":"Y Hu","year":"2019","unstructured":"Hu Y, Zhao Y, Shi C, Ren P, Wei B, Guo Y, et al. A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt\/\u03b2-catenin signaling via interacting with TET1 and miR-888. Aging. 2019;11(19):8068\u201384.","journal-title":"Aging"},{"key":"208_CR168","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/13102818.2017.1398596","volume":"32","author":"DF Chen","year":"2018","unstructured":"Chen DF, Zhang LJ, Tan K, Jing Q. Application of droplet digital PCR in quantitative detection of the cell-free circulating circRNAs. Biotechnol Biotechnol Equip. 2018;32:116\u201323.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"5978","key":"208_CR169","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1126\/science.328.5978.562","volume":"328","author":"M Leslie","year":"2010","unstructured":"Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science. 2010;328(5978):562\u20134.","journal-title":"Science"},{"issue":"7","key":"208_CR170","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.xcrm.2020.100101","volume":"1","author":"N Sol","year":"2020","unstructured":"Sol N, In \u2019t Veld S, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, et al. Tumor-educated platelet RNA for the detection and (pseudo)progression monitoring of glioblastoma. Cell Rep Med. 2020;1(7):100101.","journal-title":"Cell Rep Med"},{"issue":"1","key":"208_CR171","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-018-0768-5","volume":"37","author":"F Marchesi","year":"2018","unstructured":"Marchesi F, Regazzo G, Palombi F, Terrenato I, Sacconi A, Spagnuolo M, et al. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. J Exper Clin Cancer Res. 2018;37(1):95.","journal-title":"J Exper Clin Cancer Res"},{"issue":"1","key":"208_CR172","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13402-016-0300-x","volume":"40","author":"A Caivano","year":"2017","unstructured":"Caivano A, La Rocca F, Simeon V, Girasole M, Dinarelli S, Laurenzana I, et al. MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies\u2014a short report. Cell Oncol. 2017;40(1):97\u2013103.","journal-title":"Cell Oncol"},{"key":"208_CR173","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/jrms.JRMS_507_18","volume":"24","author":"N Zare","year":"2019","unstructured":"Zare N, Eskandari N, Mehrzad V, Javanmard SH. The expression level of hsa-miR-146a-5p in plasma-derived exosomes of patients with diffuse large B-cell lymphoma. J Res Med Sci. 2019;24:10.","journal-title":"J Res Med Sci"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-021-00208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-021-00208-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-021-00208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T05:07:45Z","timestamp":1674968865000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-021-00208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":173,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1186\/s40164-021-00208-3","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}